Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet… was recalled on August 21, 2026 in cooperation with the U.S. Food and Drug Administration because superpotent Drug.
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Lot # 504950, Exp Date: 09/30/2026.
Units affected: 1955 bottles
Where it was sold: US Nationwide.
Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.
Superpotent Drug
Class I is the most serious FDA recall level: using or being exposed to the product could cause serious health problems or death.
Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.
Contact: Recalling firm: VITRUVIAS THERAPEUTICS INC
Not sure what you're entitled to? Read our guide: what to do if your product is recalled.
Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.
View official notice →The recalled dressers are unstable if they are not anchored to the wall, posing tip-over and entrapment hazards that can result in risks of serious injuries or death to children. The dressers violate the mandatory safety standards as required by the STURDY Act.
The control board inside the motor of the recalled air conditioners can fail, posing a risk of serious injury or death from fire and burn hazards.
The recalled pressure washers lack an integral ground-fault circuit-interrupter (GFCI) and an adequate-length power cord, which may encourage use of an extension cord, posing serious risks of injury or death from shock and electrocution hazards.
Failed Stability Specifications
Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.